Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics

For Immediate ReleaseChicago, IL – July 17, 2025 – Today, Zacks Equity Research discusses Catalyst Pharmaceuticals CPRX, Zevra Therapeutics ZVRA, Theravance Biopharma TBPH, Aldeyra Therapeutics ALDX and Larimar Therapeutics LRMR.Industry: Small DrugsLink: https://www.zacks.com/commentary/2584748/5-small-drug-stocks-to-buy-amid-trumps-new-tariff-threatsThe uncertainty around tariffs and trade production measures has muted economic growth. President Trump has once again threatened...